Origin Closes Another Round
An intriguing round of follow-on funding for Halifax consumer health products maker Origin BioMed headlines a bargeful of news in the startup space today.
Origin announced yesterday it has landed $2 million in funding -- $850,000 from Nova Scotia Business Inc., $650,000 from Avrio Ventures of Calgary and $500,000 from GrowthWorks Atlantic . This builds on the total of $4.5 million that the three VCs have sunk into Origin already in the past year.
Origin manufactures natural pain relief for diabetes sufferers and the funding shows this company – which is a real veteran of the startup